phacilitate.co.uk
Interview with David Hall : Phacilitate
http://www.phacilitate.co.uk/news/interview-with-david-hall
Interview with David Hall. Interview with David Hall. Phacilitate: Please can you outline Replicel’s two autologous cell therapy technology platforms for us? Phacilitate: Okay, what are your goals and priorities for progressing Replicel’s R&D pipeline through 2015? We also have a goal to do the geographic [licence 0:03:23] for our NBDS fibreglass platform, geographic licence in Asia, in particular focused on Japan, and we will begin discussions around the generation two licence. Our final goal essent...
healthcap.eu
Portfolio Companies - HealthCap
http://www.healthcap.eu/the-investments
Senior and Special Advisors. Actelion is a Swiss biopharmaceutical company focusing on pulmonary arterial hypertension (PAH). The company listed on the Swiss Stock Exchange in 2000. Aerocrine is a medical technology company that develops and commercializes unique, easy-to-use and tailored products for the measurement of nitric oxide (NO) as an inflammatory marker for patients with inflammatory disorders, such as asthma. Aerocrine listed on the Nasdaq OMX Stockholm stock exchange in 2007. Altimmune is a c...
lhonsociety.org
LHONsociety.org :: About LHON
http://www.lhonsociety.org/about-lhon
Leber's hereditary optic neuropathy (LHON) was first described in 1871 by the German ophthalmologist Theodore Leber and was subsequently named after him. Sight of someone with LHON. 2nd image simulating potential. Sight of someone with LHON. A list of drugs reported to have mitochondrial toxicity. This paper provides some more information on environment interactions and LHON:. Gene environment interactions in Leber hereditary optic neuropathy. This site is aimed at patients and health care professionals&...
actulabo.typepad.com
Actu Labo
http://actulabo.typepad.com/actulabo/page/2
View blog top tags. Le SGS-Aster engage un plan social à Paris. Think Tank Loi Bertrand. Le Vers une application dure de la loi Bertrand? Le SGS-Aster engage un plan social à Paris. Le L’espagnol Telstar s’empare des lyophilisateurs français Usifroid. Le Eric Placet a racheté le façonnier Onyligne. Le Merck/MSD menace de fermer Organon à Eragny-sur-Epte. Le Alkopharm : fortes inquiétudes à Blois et à Quimper. Le Vérité en deçà du Channel, erreur au-delà. Le Non, non, rien n’a changé. Dans le plan Sanofi.
chminfo.wikispaces.com
CHMINFO - Cell Reprogramming, Optogenetics, etc.
http://chminfo.wikispaces.com/Cell%20Reprogramming,%20Optogenetics,%20etc.
Skip to main content. You are not a member of this wiki. Join now. Regulatory, FDA, Expedited Pathways, Access, etc. Accelerating Lab to Patient. Accelerating - Open Notebook Science. Animal and Cell Models. Audio and Video on Choroideremia Initiatives. Basic Research, Data, Registries. Cell Reprogramming, Optogenetics, etc. Clinical Trials and Pre-clinical Studies. CHM U Training Video Links. Gene Repair and Manipulation. NIH and NEI Programs. Cell Reprogramming, Optogenetics, etc. Restoration of the Ma...
phacilitate.co.uk
Register Your Interest : Phacilitate
http://www.phacilitate.co.uk/cell-and-gene-therapy-europe-enquiry
Please fill in the form below to register your interest in Cell and Gene Therapy Europe 2015. Give us your input on specific topics and speakers of interest to you - talk to a Phacilitate member of staff onsite, or email team@phacilitate.co.uk . The Most Influential Women in Cell and Gene Therapy. Ross Macdonald @ RossTheMac. Stefanos Theoharis, Walter Brooks &many more! Latest confirmed speakers for Phacilitate Leaders Europe are online. Join our upcoming webinar about # immunotherapy.
phacilitate.co.uk
Interview with Perry Karsen : Phacilitate
http://www.phacilitate.co.uk/news/interview-with-perry-karsen
Interview with Perry Karsen. Interview with Perry Karsen. Phacilitate: Celgene were one of the first major biopharma companies to actively engage and invest in the cell therapy space how do you reflect on the development of the sector over the past decade? How has the Cellular Therapeutics area evolved in terms of its status and importance within the business model of Celgene Corporation as a whole over this period? Patients. If we are able to do this, the access will come and that is the critical fa...
hsci.harvard.edu
Company Startups | Harvard Stem Cell Institute (HSCI)
http://hsci.harvard.edu/company-startups-0
Skip to main content. Https:/ www.facebook.com/HarvardStemCell. Http:/ www.youtube.com/HarvardStemCell. Subscribe to Mailing List. A key part of HSCI's mission is to help move discoveries out of the lab and into the market. One strategy is for our faculty to form startup companies based on their work. The following companies have been founded or co-founded by HSCI scientists:. Fate Therapeutics, Inc. HSCI Principal Faculty member Connie Cepko, PhD, and Affiliated Faculty member Luk Vandenberghe, PhD, are...
tandemenvue.blogspot.com
Tandem en vue: décembre 2014
http://tandemenvue.blogspot.com/2014_12_01_archive.html
L’association TANDEM EN VUE a été créée pour soutenir Raphaël Beaugillet,sportif de haut niveau malvoyant qui pratique le cyclisme . Les différents appuis apportés, qu’ils soient sous forme de temps ou de dons, réussiront à améliorer le quotidien de ce sportif . 78 rue Nationale - Cidex 502 41700 Cour-Cheverny : tandemenvue@orange.fr. Mercredi 10 décembre 2014. Aprés son accord , j. E diffuse le message d. Ce témoignage fort et important qui renforce une fois de plus l'investissement de chacun. D’u...
